---
id: WGH-MR-1980-02-05-001
guid: N/A
type: medical-record
subtype: chemotherapy-treatment-plan
title: Chemotherapy Treatment Plan and Initial Administration Record
author: Dr. Jennifer Walsh
recipient: Oncology Nursing Staff
organization: Woburn General Hospital
date: 1980-02-05
timestamp: 1980-02-05_09:15
period: period-5
related_legal_elements: Negligence, Damages, Conscious Pain and Suffering
---

# WOBURN GENERAL HOSPITAL
## ONCOLOGY DEPARTMENT
### CHEMOTHERAPY TREATMENT PLAN AND INITIAL ADMINISTRATION RECORD

**Patient Information:**
- Name: Anderson, James P.
- Medical Record Number: WGH-78-4521
- Date of Birth: March 15, 1970
- Age: 9 years, 10 months
- Address: 42 Pine Street, East Woburn, MA 01801
- Guardian: Anne Anderson (Mother)
- Primary Physician: Dr. Jennifer Walsh, MD
- Date of Record: February 5, 1980
- Time: 09:15 AM

**Diagnosis:**
Primary: Acute Lymphoblastic Leukemia (ALL), B-cell precursor type
Secondary: Anemia secondary to leukemia
Tertiary: Thrombocytopenia

**Medical History:**
Patient presented in November 1979 with fatigue, pallor, and recurrent infections. Initial complete blood count revealed severe leukocytosis with blast cells comprising 85% of white blood cell differential. Bone marrow biopsy confirmed diagnosis of acute lymphoblastic leukemia. Patient resides in East Woburn area served by municipal Wells G and H prior to their closure in May 1979. Family reports exclusive use of municipal water supply for drinking, cooking, and bathing throughout patient's lifetime.

**Current Clinical Status:**
- Weight: 62 pounds (28.1 kg)
- Height: 52 inches
- Performance Status: ECOG 2
- Central venous access: Hickman catheter placed January 28, 1980

**Laboratory Values (February 4, 1980):**
- Hemoglobin: 7.2 g/dL
- Hematocrit: 21.8%
- White Blood Count: 47,500/μL
- Platelet Count: 28,000/μL
- Absolute Neutrophil Count: 425/μL
- Serum Creatinine: 0.6 mg/dL
- Total Bilirubin: 1.1 mg/dL
- ALT: 42 U/L
- AST: 38 U/L

**Treatment Protocol:**
Modified Dana-Farber ALL Consortium Protocol 79-01
Phase: Induction Chemotherapy (Week 1 of 4-week cycle)

**Chemotherapy Regimen - Day 1:**

### Vincristine Sulfate
- Dose: 1.5 mg/m² IV push
- Calculated dose: 0.6 mg (based on BSA 0.4 m²)
- Administration time: 10:00 AM
- Route: Intravenous push via Hickman catheter
- Precautions: Monitor for peripheral neuropathy, constipation

### Prednisone
- Dose: 40 mg/m² PO daily
- Calculated dose: 16 mg daily
- Schedule: Divided into 8 mg twice daily with meals
- Duration: Days 1-28 with tapering schedule

### L-Asparaginase
- Dose: 6,000 IU/m² IM
- Calculated dose: 2,400 IU
- Administration: Intramuscular injection, right vastus lateralis
- Time: 11:30 AM
- Precautions: Monitor for allergic reaction, have epinephrine available

**Pre-medication Protocol:**
- Ondansetron 4 mg IV 30 minutes prior to chemotherapy
- Diphenhydramine 25 mg IV for potential allergic reactions
- Hydration: Normal saline 500 mL IV over 2 hours

**Monitoring Requirements:**
- Vital signs every 15 minutes during infusion, then hourly for 4 hours
- Neurological assessment every 2 hours for 8 hours post-vincristine
- Daily weight and intake/output monitoring
- Complete blood count with differential every 3 days
- Comprehensive metabolic panel twice weekly
- Liver function tests weekly

**Supportive Care Measures:**
- Allopurinol 100 mg PO daily for tumor lysis syndrome prevention
- Trimethoprim-sulfamethoxazole prophylaxis (held due to low ANC)
- Mouth care protocol with sodium bicarbonate rinses
- Nutritional consultation for caloric support

**Special Considerations:**
Patient exhibits significant anxiety regarding treatment. Mother reports family stress related to recent diagnosis and concerns about environmental factors in East Woburn community. Social work consultation arranged for psychosocial support. Patient's residence in area previously served by contaminated municipal water supply noted in medical record per hospital protocol established December 1979.

**Nursing Instructions:**
1. Verify patient identity using two identifiers before medication administration
2. Use aseptic technique for all central line access
3. Monitor insertion site for signs of infection
4. Assess for signs of tumor lysis syndrome: altered mental status, cardiac arrhythmias, seizures
5. Document all intake and output accurately
6. Report fever >100.4°F immediately to physician
7. Maintain strict isolation precautions due to neutropenia
8. Provide emotional support to patient and family

**Expected Side Effects:**
- Nausea and vomiting (moderate to severe)
- Bone marrow suppression with nadir at 7-14 days
- Alopecia beginning 2-3 weeks post-treatment
- Peripheral neuropathy (cumulative with vincristine)
- Mood changes and increased appetite (prednisone)
- Potential allergic reaction to L-asparaginase

**Emergency Protocols:**
- Allergic reaction: Stop infusion, administer epinephrine, corticosteroids, supportive care
- Extravasation: Stop infusion, aspirate residual drug, apply ice, notify physician
- Fever in neutropenic patient: Blood cultures, broad-spectrum antibiotics per protocol

**Next Scheduled Treatment:**
February 12, 1980 (Day 8) - Vincristine 0.6 mg IV push
Continue daily prednisone as prescribed
Weekly L-asparaginase per protocol schedule

**Physician Orders:**
- Continue current regimen as outlined
- Platelet transfusion if count <20,000/μL or active bleeding
- Packed red blood cell transfusion if hemoglobin <7.0 g/dL
- Notify physician for any temperature elevation, bleeding, or neurological changes
- Social work and child life specialist consultation

**Documentation:**
Treatment plan reviewed with oncology nursing staff. All medications prepared and verified by two registered nurses per hospital policy. Patient and guardian provided with written information regarding chemotherapy side effects and emergency contact procedures. Interpreter services not required.

**Physician Signature:**
Jennifer Walsh, MD  
Staff Oncologist  
Massachusetts Medical License #12847  
Date: February 5, 1980  
Time: 09:15 AM

**Nursing Verification:**
Mary Catherine Sullivan, RN  
Oncology Unit Charge Nurse  
Date: February 5, 1980  
Time: 09:20 AM

---

*This record constitutes part of the official medical documentation for patient care and may be subject to legal discovery proceedings. All entries must be accurate, complete, and contemporaneous with patient care activities.*